Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
New Beginnings For Chemours And DuPont
by Marc S. Reisch
July 6, 2015
| A version of this story appeared in
Volume 93, Issue 27
Mark P. Vergnano, CEO of Chemours, rang the opening bell at the New York Stock Exchange on June 29, just two days before trading in Chemours, DuPont’s former performance chemicals business, began under the symbol CC. Later on June 29, DuPont CEO Ellen J. Kullman rang the closing bell at the exchange to mark the spin-off and the beginning of a new era for the more than 200-year-old firm. DuPont is now focused on biobased chemicals, agriculture, nutrition, and advanced materials.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter